Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
New Drug Application
Biotech
Vertex inches closer to acute pain market as FDA accepts VX-548
Vertex is inching closer to bringing a non-opioid pain med to market, with the FDA accepting an NDA submission for VX-548, now dubbed suzetrigine.
Gabrielle Masson
Apr 18, 2024 10:50am
Milestone resubmits NDA, Aldeyra readies 2nd chance filing
Mar 28, 2024 10:40am
Tonix signs CRO deal, preps FDA app for fibromyalgia drug
Feb 14, 2024 12:52pm
First-ever drug application for MDMA finally reaches FDA
Dec 13, 2023 9:39am
Karuna's new schizophrenia drug reaches FDA's desk
Sep 28, 2023 11:12am
Beam's light scatters as FDA blocks phase 1 study for CAR-T
Aug 1, 2022 9:28am